Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
A

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the Clinical and Biologic Features of Successfully Monitored MCL Patients?

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Anita Kumar
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Anita Kumar
0 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Mantle Cell Lymphoma
12:35
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

2019 Frontline Therapy for Mantle Cell Lymphoma: Cytarabine as a Key…

Feat. S. Rule
15:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Novel Salvage Therapy in Mantle Cell Lymphoma: Discussion on Agents …

Feat. S. Rule
15:47
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the …

Feat. A. Kumar
11:48
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Safety and Efficacy of Acalabrutinib + Bendamustine / Rituximab in P…

Feat. M. Wang